To evaluate efficacy we used an in vivo model of focal ischemic stroke22–24 and analyzed infarct volume, behavioral functional recovery, as well as the ability of PEG-IGF-I to augment axonal sprouting, gliosis and neurogenesis post-stroke. This evidence concerns the gene IGF1 and Stroke.